Get started
Author

Tamás Zelei

Observed names: T Zelei, T. Zelei, Zelei, Tamas, Zelei, Tamás
ORCID: 0000-0003-1961-9607
Observed ORCID: 0000-0003-1961-9607
OpenAlex ID: A5008503625
Policy objective of generic medicines from the investment perspective: The case of clopidogrel
2017 · Péter Elek, András Harsányi, et al. · Health Policy · 136
Epidemiology of Sanfilippo syndrome: results of a systematic literature review
2018 · Tamás Zelei, Kata Csetneki, et al. · Orphanet Journal of Rare Diseases · 84
PDF
Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries
2016 · Tamás Zelei, Mária J. Molnár, et al. · Orphanet Journal of Rare Diseases · 76
PDF
Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency
2019 · Tímea Almási, Lin T. Guey, et al. · Orphanet Journal of Rare Diseases · 75
PDF
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options
2022 · Rositsa Koleva-Kolarova, James Buchanan, et al. · Applied Health Economics and Health Policy · 69
PDF
The European challenges of funding orphan medicinal products
2018 · Márta Szegedi, Tamás Zelei, et al. · Orphanet Journal of Rare Diseases · 67
PDF
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis
2022 · Heleen Vellekoop, Matthijs Versteegh, et al. · Value in Health · 49
PDF
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine
2021 · Heleen Vellekoop, Simone Huygens, et al. · PharmacoEconomics · 46
PDF
Systematic literature review and meta-analysis on the epidemiology of propionic acidemia
2019 · Tímea Almási, Lin T. Guey, et al. · Orphanet Journal of Rare Diseases · 40
Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review
2021 · Tamás Zelei, Nicholas D. Mendola, et al. · PharmacoEconomics - Open · 26
PDF
Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib
2022 · Simone Huygens, Heleen Vellekoop, et al. · Value in Health · 16
PDF
Beyond medicines’ barriers: exploring the true cost of multiple myeloma
2022 · Mimi Choon-Quinones, Tamás Zelei, et al. · Journal of Medical Economics · 13
PDF
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation
2023 · Rositsa Koleva-Kolarova, László Szilberhorn, et al. · Personalized Medicine · 11
PDF
Association between transplant glomerulopathy and graft outcomes following kidney transplantation: A meta-analysis
2020 · Gábor Kovács, Giovanna Devercelli, et al. · PLoS ONE · 11
PDF
Systematic literature review of health economic models developed for multiple myeloma to support future analyses
2022 · Mimi Choon-Quinones, Tamás Zelei, et al. · Journal of Medical Economics · 9
Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids
2022 · Mimi Choon-Quinones, Dirk Hose, et al. · Value in Health · 9
PDF
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK
2023 · Rositsa Koleva-Kolarova, Heleen Vellekoop, et al. · Personalized Medicine · 8
Cost–effectiveness of Genetic-Based Screening Strategies for Maturity-Onset Diabetes of the Young
2023 · Gábor Kovács, Dávid Nagy, et al. · Personalized Medicine · 8
Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis
2016 · G. Kovács, T. Zelei, et al. · Climacteric · 8
Incidence of staphylococcus aureus infections after surgical interventions: a systematic review and meta-analysis
2025 · Baher Elezbawy, Nada Abaza, et al. · Expert Review of Anti-infective Therapy · 7
Systematic literature review of the epidemiology of glycogen storage disease type 1a
2023 · Tamás Zelei, Sándor Kovács, et al. · Journal of Pediatric Endocrinology and Metabolism · 7
PDF
Budget Impact and Transferability of Cost–effectiveness of DPYD Testing in Metastatic Breast Cancer in Three Health Systems
2023 · Rositsa Koleva-Kolarova, Heleen Vellekoop, et al. · Personalized Medicine · 6
Cost–effectiveness of Alternative NTRK Testing Strategies in Cancer Patients Followed by Histology-Independent Therapy with Entrectinib: an Analysis of Three European Countries
2023 · Heleen Vellekoop, Simone Huygens, et al. · Personalized Medicine · 6
Survival of propionic acidemia patients with liver transplant
2024 · Tamás Zelei, Zoltán Vokó, et al. · Molecular Genetics and Metabolism Reports · 5
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries
2023 · László Szilberhorn, Tamás Zelei, et al. · Personalized Medicine · 3
Works count: 66
Citation count: 804
H-index: 12
I10-index: 14
Year
Topic
Type